baber/WOPTO huggingface dataset:
Patent JP-H09511191-A (JP)
IPC: C08L69/00
Filed: 1995-03-16
Abstract: A method for making improved optical quality lenses is described. The method includes arranging a mold having a molding surface, a curable optical quality resin composition, and a plastic lens preform of optical quality material such that the resin composition is disposed between, and in contact with, the plastic lens preform and the mold. Upon curing, the resin composition forms a cured plastic attached portion that is bonded to the plastic lens preform. The resin composition and plastic lens preform are selected such that the attached portion has a higher scratch resistance, a lower chromatic aberration, and/or a higher ease of edging than the lens preform.
Patent JP-H10509328-A (JP)
IPC: C12Q1/6883
Filed: 1995-02-14
Abstract: A human polypeptide and DNA (RNA) encoding such polypeptide and procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating epithelial cell growth which may be used to stimulate wound healing, reduce scarring and prevent hair loss. Antagonists against such polypeptides and their use as a therapeutic to treat proliferative diseases such as cancer, psoriasis, Kaposi's sarcoma, keloids, retinopathy and restenosis are also disclosed. Diagnostic methods for detecting mutations in the KGF-2 coding sequence and alterations in the concentration of KGF-2 protein in a sample derived from a host are also disclosed. <IMAGE>
Patent JP-2000515213-A (JP)
Title: 三サイクルエンジン
IPC: F01B9/06
Filed: 1997-01-20
Abstract: (57)【要約】
孔（１０）内で摺動するピストン（１２）を備える往復動ピストン装置において、ピストン（１２）の直線運動を回転運動に変換するクランク組立体が設けられる。この組立体は連結棹（１４）を備え、この連結棹は一端でピストン（１２）に連結され、他端で遊星歯車（１６）に連結される。遊星歯車（１６）は、係合する輪歯車（１８）内で回転するように取り付けられる。遊星歯車（１６）は、輪歯車（１８）の軸と同軸の軸（２４）のまわりを回転するクランク（２２）に回転自在に取り付けられる。遊星歯車（１６）は、軸（２４）から偏位した軸（２６）上でクランク（２２）に回転自在に取り付けられる。好ましくは、遊星歯車（１６）の径は輪歯車（１８）の径の２／３とする。遊星歯車（１６）の回転にしたがって、ピストンはある時間で下方に移動し、同様の時間で下方死点又はその近傍に留まり、次いで同じ時間で上方死点に戻る。
Patent JP-H08510150-A (JP)
Title: 吸収性物品
IPC: A61F13/15
Filed: 1994-05-05
Abstract: (57)【要約】
尿、月経、血液、排出物等の体液を吸収するための、吸収性物品を開示する。この吸収性物品は液体透過性カバー（36）、液体不透過性バッフル（38）およびこれらの間に配置された吸収材を含む。該吸収材は、それぞれ所定の幅を有する第一（44）および第二（46）の部材から作られ、該第一の部材の幅は該第二の部材の幅に等しいか、あるいはこれよりも大きい。該第二の部材は該第一の部材の少なくとも一部の下部に配置されている。該第二の部材は該第一の部材よりも高い吸収能を有し、このことは該第二の部材全体に渡る、水平面内での体液の移動を容易にする。該第二の部材中に存在する該体液は、次いで該第二の部材の飽和された面積に等しい面積に渡り、該第一の部材に戻されるであろう。該第二の部材は２層以上含むことができ、該複数の層は別々の異なる層で構成されるか、あるいは単一の薄葉紙シートを１回以上折り曲げることにより形成される。
Patent JP-H08510171-A (JP)
Title: 圧力溶浸鋳造方法及び圧力溶浸鋳造装置
IPC: B22D19/14
Filed: 1994-05-09
Abstract: (57)【要約】
鋳型キャビティ２０及び浸透物チャージ１４の予備加熱、排気ステップが、鋳型キャビティ２０が浸透物で満たされる圧力容器とは別の容器内で実行され、これに大きな最終物品のスループットが達成される圧力溶浸鋳造方法が提供される。圧力溶浸鋳造装置も同様に提供される。
Patent JP-H11500673-A (JP)
Title: 色むら防止フィルムまたはコーティング
IPC: B32B7/12
Filed: 1995-08-22
Abstract: (57)【要約】
複合構築物(10)が記載される。これは(A)表側および背側を有する可塑化ポリマーフィルム層(6)；(B)該可塑化ポリマーフィルム層(6)の背側に接する１つの面を有する剥離コートライナー(2)を備え；そして(C)該剥離コートライナー(B,2)の他の面上の可塑剤耐性ポリマーバックコーティング(4)であって、(A)中の可塑剤に対して実質的に不透過性のバックコーティング(4)；または(D)該可塑化ポリマーフィルム層(A,6)の表側に接する、除去可能な可塑剤耐性ポリマーフィルム(18)のいずれかを備える。このような複合構築物(10)は、それ自身の上にロール形態に巻き取り可能であり、かつ使用時に容易にほどかれ得る。ほどかれたとき、ビニルフィルム(6)の表面上の色むらの存在は最小化されるか、あるいは排除されることが観察される。本発明はまたこのような複合体(10)の製造方法に関する。
Patent JP-H11514386-A (JP)
Title: 合成樹脂滑り層を持つ軸受のための複合材料の製造方法並びにこれに適するペースト
IPC: C08K3/00
Filed: 1996-02-23
Abstract: (57)【要約】
本発明の方法に従って、合成樹脂滑り層を形成するために最初にペーストを合成樹脂分散物とフィラーとから製造する。このペーストは有機溶剤を含有しておらず、焼結された多孔質層に塗布される。得られる多層物質を次いで焼結する。有機溶剤を使用しないので、衛生上の危険および火災の危険が著しく減少する。更に、本発明に従って製造される複合体は優れた耐空洞化性を有している。それ故に、軸受の如き無潤滑製品の慣用の用途分野に加えて、これらの複合材料はギヤ式ポンプおよびショックアブソーバーにも使用できる。
Patent JP-H09512176-A (JP)
IPC: A61K35/14
Filed: 1995-04-20
Abstract: A bifunctional protein comprising: 1) a single-chain antibody directed against a suitable antigen on a tumour cell, 2) a hinge region comprising from about 40 to about 200 amino acids joined to the V<SUB>L </SUB>domain of the single chain antibody, and 3) a functional zeta (zeta) chain from the T-cell antigen receptor (TCR) joined to the hinge region, wherein the hinge region is an immunoglobin-like hinge region which is joined to the C-terminus of the V<SUB>L </SUB>domain of the single-chain antibody. The functional zeta (zeta) chain comprises the transmembrane and the cytoplasmic domain. The bifunctional protein can be expressed using a cytotoxic lymphocyte (CTL) expressing DNA encoding it.
Patent JP-2001509844-A (JP)
Title: 乗物のエアバッグ用織布
IPC: C09D1/00
Filed: 1997-09-29
Abstract: (57)【要約】
本発明は、合成繊維、好ましくはポリアミドから作られ、高い引張及び引裂強度を有する布を構成し、動力車に利用される衝撃保護用の膨張式エアバッグの材料として使用されるように意図されている織物に関する。エアバッグの内面を形成する織物の面上には、コーティングが施される。このコーティングは、熱反射特性を有する顔料を混入した一又は数層のポリマーから構成される。
Patent JP-H11503121-A (JP)
Title: アミジン誘導体
IPC: A61K31/425
Filed: 1996-03-26
Abstract: (57)【要約】
式
 ［式中、Ｒ 1 は複素環基、Ｘは（ＣＨ 2 ） a （式中、ａは０または１）、ＯまたはＳ、ＹはＣＨ 2 、Ｏ、ＳまたはＮ−Ｒ 2 （式中、Ｒ 2 は水素または低級アルキル基）、ＺはＯまたはＨ 2 、ｍおよびｎはそれぞれ０または１、をそれぞれ意味する。］で表される化合物および医薬として許容されるその塩であって、ＮＯＳ媒介疾患の予防および治療のための医薬として有用である。
Patent JP-H11502903-A (JP)
Title: 予湿分性の、水に流せる使い捨て生分解性ウェットワイプ
IPC: D04H1/64
Filed: 1996-03-08
Abstract: (57)【要約】
本発明は、PVOHを含むバインダーと接触された不織繊維のウェブからなる予湿分性の分散性、生分解性ウェットワイプを提供する。バインダー接触ウェブは、約0.1 から約0.9 重量％のホウ酸と、約５から約8 重量％のアルカリ金属重炭酸塩とからなる水性ローション溶液を含む。この結果得られるウェットワイプは、約7 から約9 のpHと、約8 から約20オンス/ インチの湿潤強度とを有する。
Patent JP-2001508137-A (JP)
IPC: D21H23/04
Filed: 1997-12-09
Abstract: PCT No. PCT/EP97/06857 Sec. 371 Date Jan. 27, 1999 Sec. 102(e) Date Jan. 27, 1999 PCT Filed Dec. 9, 1997 PCT Pub. No. WO98/29603 PCT Pub. Date Jul. 9, 1998Paper is produced by draining a paper stock containing process chemicals on a paper machine, a main stream of the paper stock and a dilution stream which consists of white water, contains at least 5% by weight of the process chemicals and amounts to 5-35% by volume of the total head box feed being fed via a head box to the paper machine wire. The papers thus produced have an excellent formation profile and an outstanding ash distribution.
Patent JP-2000505506-A (JP)
Title: 溶融亜鉛メッキ浴およびその方法
IPC: C23C2/06
Filed: 1997-02-20
Abstract: (57)【要約】
被膜厚に関する亜鉛メッキされる鋼材のケイ素含有量の影響を減少するための亜鉛浴であって、３ないし１５重量％の錫、飽和までの濃度の鉛、並びに０ないし０．０６重量％のアルミニウム、カルシウムおよびマグネシウムのうち少なくとも１種を含み、残部は亜鉛および不可避の不純物であり、特に、鋼材製品を回分式に亜鉛メッキするために有用である浴。
Patent JP-H10500452-A (JP)
IPC: C23C22/10
Filed: 1995-05-12
Abstract: PCT No. PCT/EP95/01815 Sec. 371 Date Sep. 9, 1997 Sec. 102(e) Date Sep. 9, 1997 PCT Filed May 12, 1995 PCT Pub. No. WO95/32319 PCT Pub. Date Nov. 30, 1995Described are a concentrate, a working solution and a process for iron phosphating of metals, in which the solution contains nitrobenzene sulfonic acid and substituted short-chain monocarboxylic acids of the amino acid and/or hydroxycarboxylic acid type as the accelerators.
Patent JP-2000505303-A (JP)
IPC: A23L29/00
Filed: 1997-02-28
Abstract: The present invention relates to an enzyme with galactanase activity, a DNA construct encoding the enzyme with galactanase activity, a method of producing the enzyme, an enzyme composition comprising the enzyme with galactanase activity, and the use of the galactanase enzyme and enzyme composition for a number of industrial applications.
Patent JP-H11503775-A (JP)
Title: ジチオオキサミド接着促進剤含有エポキシ接着剤
IPC: C09J11/06
Filed: 1996-02-20
Abstract: (57)【要約】
本発明は、（ａ）エポキシ樹脂、（ｂ）前記エポキシ樹脂の硬化剤、および（ｃ）式Ｉの化合物
 （Ｒ 1 およびＲ 2 は、同一でも異なっていてもよく、アルキル基、ヒドロキシアルキル基、シクロアルキル基、アリール基、アリールアルキル基またはＳ、ＮおよびＯから独立に選択される１〜３個の非炭素原子を環に含む複素環基から選択される）を含む硬化性構造エポキシ接着剤を提供する。
Patent JP-2001504858-A (JP)
IPC: A61K31/7084
Filed: 1998-02-06
Abstract: A method and preparation for the stimulation of tear secretion in a subject in need of such treatment is disclosed. The method comprises administering to the ocular surfaces of the subject a purinergic receptor agonist such as uridine 5′-triphosphate (UTP), dinucleotides, cytidine 5′-triphosphate (CTP), adenosine 5′-triphosphate (ATP), or their therapeutically useful analogs and derivatives, in an amount effective to stimulate tear fluid secretion and enhance drainage of the lacrimal system. Pharmaceutical formulations and methods of making the same are also disclosed. Methods of administering the same would include: topical administration via a liquid, gel, cream, or as part of a contact lens or selective release membrane; or systemic administration via nasal drops or spray, inhalation by nebulizer or other device, oral form (liquid or pill), injectable, intra-operative instillation or suppository form.
Patent JP-2001511848-A (JP)
IPC: C25D3/10
Filed: 1998-02-11
Abstract: C1-C18 Alkylsulfonic or Alkyldisulfonic compounds and Aminoalkilsulfonic acids or salts thereof, are used as additives in chromium plating baths to reduce anodic corrosion, improve the covering and penetrating power of the bath, reduce the surface-tension and give a bright deposit. <IMAGE>
Patent JP-2000515847-A (JP)
IPC: A61K9/00
Filed: 1996-05-22
Abstract: The invention relates to radiotherapy with somatostatin-derived peptides labeled with medically useful metal ions. The invention in particular provides for methods and reagents for labeling somatostatin-derived peptides with perrhenate, in which a solution including somatostatin-derived peptide analogue containing at least one disulfide bond is provided, the solution is reacted with stannous ions and with a radioisotope, wherein the stannous ions are sufficient to substantially reduce the disulfide bonds of the peptide and the radioisotope, and the radiolabeled somatostatin-derived peptide analogue recovered. Also provided are methods for regional administration of radiolabeled somatostatin-derived peptides, methods for enhanced regional retention of radiolabeled somatostatin-derived peptides, methods for treatment of arthritis using radiolabeled somatostatin derived peptides, and methods for stabilizing radiolabeled somatostatin derived peptides.
Patent JP-2000508270-A (JP)
Title: エアーバッグ用布帛
IPC: B60R21/16
Filed: 1996-07-30
Abstract: (57)【要約】
エアーバッグ全体またはその一部分の構造に使用するのに適した布帛（１０）は、複数の補強層（２３）を有する。補強層（２３）は互いに接合されて一体状のシートを形成している。補強層（２３）は熱可塑性フィルム、不織布ウエブ又は被覆物等の材料に略平行な繊維を付着した一方向性の積層体によって形成することができる。布帛（１０）どうしを縫製又は熱加工により接合させてエアーバッグに組み立てることができる。
Patent JP-2001522321-A (JP)
IPC: B29C65/08
Filed: 1998-02-17
Abstract: An anvil system (36) including a plurality of anvils (20) having an interconnected cooling system (39,40). Each of the anvils (20) has means for acoustically insulating (28,52) the anvil body (23) from ultrasonic energy which originates from an ultrasonic horn (72). The insulation means (28,52) may be an airspace slot (28) essentially separating the vibrating portion of the anvil from the anvil body. The anvil (20) may also have an adjustable sealing pattern (26) which allows for facilitated exchange of sealing patterns (26). The anvil (20) may also have a plurality of projecting pads (76) which reduces damage to the ultrasonic sealing equipment and to the object to be sealed. <IMAGE>
Patent JP-2001515478-A (JP)
Title: ７α−メチル−１７α−エチニル−エストラン誘導体のアテローム動脈硬化症の治療のための使用
IPC: C07J1/00
Filed: 1998-03-03
Abstract: (57)【要約】
本発明は、アテローム動脈硬化症の予防または治療用薬剤の製造のための一般式（Ｉ）：
 （式中、Ｒ 1 はＨ（ＯＲ 3 ）またはＯであり、Ｒ 2 はＨまたは（Ｃ 1-18 ）アシルであり、Ｒ 3 はＨまたは（Ｃ 1-18 ）アシルであり、波線は４，５−位または５，１０−位の二重結合を示す）を有する７α−メチル−１７α−エチニル−エストラン誘導体の使用に関する。
Patent JP-2001519871-A (JP)
IPC: F16L21/08
Filed: 1998-02-17
Abstract: The invention relates to an article of manufacture comprising a partial or complete tubular primary part defining a tube axis and having an at least partially curved circumferential wall at least partially encircling the axis; said wall comprising a joint edge, defining a) a joint line along said edge on said wall, b) a joint plane drawn to contain said joint line, c) a joining direction having at least a direction component perpendicular to said joint line and said joint plane, d) a locking plane at least partially at the surface or within a section through said wall in which both said joint line and said joining direction lie and e) a normal direction being perpendicular to said joint plane; and at least one locking structure, the improvement comprising that the locking structure includes at least one positive or negative hook structure in said locking plane, extending in the joining direction away from the joint line and having an undercut in the locking plane and that the hook structure is exposed from at least one side of the locking plane when viewed along the normal direction. The invention also relates to a method for joining such a primary part to a secondary part and joined such parts.
Patent JP-2001514695-A (JP)
Title: ポリアミド組成物から作られた自動車部品
IPC: C08L77/06
Filed: 1998-03-12
Abstract: (57)【要約】
脂肪族ジカルボン酸と脂肪族ジアミンとから誘導される単位から実質的に成るポリアミド組成物から作られ、および、鎖単位の１〜約40重量％が、１または２以上の脂環式ジカルボン酸と脂肪族ジアミンとから、または、１または２以上の脂環式ジアミンと脂肪族ジカルボン酸とから誘導されたポリアミド組成物から作られた自動車部品。
Patent JP-2001514698-A (JP)
Title: 洗剤組成物用の選択された結晶性炭酸カルシウムビルダー
IPC: C11D3/12
Filed: 1998-03-06
Abstract: (57)【要約】
選択された結晶炭酸カルシウムの形態の安価な洗剤ビルダーを含有する洗剤組成物が提供される。特に、この結晶炭酸カルシウムは、｛１，０，−１，１｝結晶指数の斜方面体晶系結晶構造を実質的に有する。この結晶炭酸カルシウムは、｛１，０，−１，１｝指数の斜方面体晶系結晶構造に特別に変性させてある方解石とすることができる。本発明の結晶炭酸カルシウムは、安価な天然に産出する方解石から容易に形成させることができるため非常に安価であり、大きな中央値の粒子サイズで用いたとしても存分に性能を発揮する。
Patent JP-2000511240-A (JP)
IPC: D01F6/96
Filed: 1997-05-29
Abstract: An elastic fiber of a mixture containing a copolyether ester or a copolyester ester and a chemically crosslinked rubber, which fiber has a permanent elongation after 100% stretching of at most 9% and an elongation at break of at least 450% and a process for producing an elastic fiber comprising the melt spinning of a mixture of a copolyether ester or a copolyester ester and a rubber to form a fiber, in which the rubber is completely or almost completely crosslinked at the moment the fiber is formed, and are disclosed.
Patent JP-2001525865-A (JP)
Title: １，２，３，４−テトラヒドロ（１−フェニルエチル）ナフタレン含有熱流体ブレンド物
IPC: C09K5/10
Filed: 1998-04-30
Abstract: (57)【要約】
１，２，３，４−テトラヒドロ（１−フェニルエチル）ナフタレンとジベンジルトルエンの混合物からなり優れた熱安定性を示す高温熱伝達流体を開示する。
Patent MD-20040204-A (MD)
Title: Security document with integrated circuit
Inventor: DUMERY THIERRY
IPC: G06K19/077
Filed: 2003-02-19
Abstract: The invention relates to a process for manufacture of a security document comprising an integrated circuit, characterized in that the integrated circuit is constituted directly onto one part of the document.
Patent MX-159771-A (MX)
Inventor: DOUCHY MICHEL
IPC: C21C7/06
Filed: 1984-03-02
Abstract: The invention concerns a composite product, also referred to as cored wire, comprising a tubular metal casing having a welt-type seam, containing a core of compacted powder or granular material, which can be easily rolled up and then unrolled, without the risk of the seam coming undone. The composite product according to the invention comprises, on the outside wall of the casing and straddling the seam region, hollow impressed portions which are produced by cold deformation of the metal. These portions are in the form of grooves which are elongate transversely with respect to the axis of the composite product. The composite product according to the invention is used, in particular, for treating metal baths.
Patent NZ-193923-A (NZ)
Title: Electric control device in central heating boiler system
Inventor: OVERMAN P
IPC: F24H9/20
Filed: 1980-06-04
Abstract: An electric control device for a central heating boiler which is provided with a water pump or an air ventilator (6), a burner with an electrically operated shut-off valve (5) and an electric control circuit comprising a supply transformer (1) and a series circuit connected to the secondary winding of said transformer and composed of the control winding (4) of the shut-off valve (5), the contact of a room or regulator thermostat (3) and, if present, the contact of a maximum thermostat (2) and in which the water pump or air ventilator (6) is connected in parallel with the primary winding of the supply transformer. The control device comprises a circuit to be connected to the contact of the room or regulator thermostat (3) including a high resistance value series resistor (Rs) to be connected into the mains supply circuit of the boiler, a relay (13) with a normally open contact (k) connected in parallel to said series resistor (Rs) and means (10,11,12) for controlling the relay (13) in such manner that the water pump or air ventilator is put into operation only upon the closing of the contact of the room or regulator thermostat and the opening of the contact of the maximum thermostat respectively through the closing of the contact (k) of the relay (13).
Patent NZ-206355-A (NZ)
Title: Non-corrosive detergent composition containing silica
Inventor: DONKER C B
IPC: C11D3/00
Filed: 1983-11-22
Abstract: The invention pertains to aqueous liquid detergent compositions having improved non-corrosive properties which comprise an effective amount of silica having a surface area greater than 200 m<2>/gram. The inclusion of silica provides good non-corrosive properties both in respect to metal and enamel surfaces.
Patent NZ-219282-A (NZ)
Title: Glycol monoethers
Inventor: NYFELER R
IPC: C07D249/08
Filed: 1984-05-18
Abstract: Essentially, a process is described for the preparation of the 1-triazolylethyl ether derivatives, defined in claim 1, of the general formula I   <IMAGE> (I)  which consists in (a) reacting an oxirane of the formula II   <IMAGE> (II)   at temperatures of -20 DEG to +100 DEG  C., in the presence of an acid catalyst or an acid condensation agent, with an alcohol of the formula III R3-OH (III) to give a glycol monoether of the formula IV   <IMAGE> (IV)   and (b) subsequently reacting the glycol monoether of the formula IV or one of its esters, in the presence of an acid-binding agent or condensation agent, at temperatures of 0 DEG  to 150 DEG  C., with a triazole of the formula V   <IMAGE> (V)   the substituents R1, R2 ; amd R3 in the formula II to IV being as defined under formula I and M in formula V being hydrogen or a metal atom. The novel compounds within the scope of formula I and their use are also described.
Patent NZ-222051-A (NZ)
Title: Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
Inventor: MENTZER ROBERT M
IPC: C07H19/167
Filed: 1987-10-05
Abstract: The invention relates to an improved cardioplegic solution for reducing ischemic damage to the heart during operations and/or transplantation. The invented solution contains adenosine, hypoxanthine and ribose in addition to the electrolytes contained in standard cardioplegic solutions.
Patent NZ-222608-A (NZ)
Title: Substituted aminomethane diphosphonic acids, preparation thereof and pharmaceutical compositions
Inventor: WIDLER LEO
IPC: C07F9/547
Filed: 1987-11-19
Abstract: Heteroarylaminomethanediphosphonic acids of the formula <IMAGE> in which R1 represents an optionally benzo- or cyclohexeno-fused 5-membered heteroaryl radical having 2 to 4 N atoms or 1 or 2 N atoms and 1 O or S atom as hetero atom(s) and which is unsubstituted or substituted by lower alkyl, phenyl which is unsubstituted or substituted by lower alkyl, lower alkoxy and/or halogen, lower alkoxy, hydroxyl, di-lower alkylamino, lower alkylthio and/or halogen and R2 denotes hydrogen or lower alkyl, and their salts have an action regulating the metabolism of calcium and can be used as pharmaceutical active compounds for the treatment of diseases which can be traced back to disorders thereof. They are prepared, for example, by converting the group(s) X into free phosphono in a compound of the formula <IMAGE> in which X1 denotes a functionally modified phosphono group X and X2 denotes phosphono or likewise a functionally modified phosphono group X.
Patent NZ-237213-A (NZ)
Title: 6-substituted hexahydrobenz[cd]indole derivatives and pharmaceutical compositions
Inventor: FLAUGH MICHAEL EDWARD
IPC: A61P9/12
Filed: 1991-02-25
Abstract: The present invention provides 4-amino-6-substituted-hexahydrobenz[cd]indoles which are useful in treating disease states which can be benefited by an alteration of function at 5- @  @ receptors.
Patent NZ-242818-A (NZ)
Title: Diastereoselective synthesis of cis-nucleosides and their analogues; intermediates therefor
Inventor: MANSOUR TAREK S
IPC: C07D411/12
Filed: 1992-05-20
Abstract: The present invention relates to highly diastereoselective processes for production of cis-nucleosides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.
Patent NZ-247767-A (NZ)
Title: Infusion stopper and spike for parenteral liquid in vial: inwardly directed annular protrusion on stopper skirt portion forms secondary seal with spike
Inventor: TIRRELL JOSEPH V
IPC: B65D41/40
Filed: 1993-06-02
Abstract: An elastomeric stopper (10) for a fluid-containing container (40) to hermetically seal the content therein and to provide access thereto by the insertion of an infusion device (60) through the stopper(10), the stopper (10) comprising a skirt portion (20) having an annular protuberance (26) projecting inwardly and forming a seal with the infusion device (60) upon its insertion into the container (40) through the stopper (10), to prevent leakage, blow-out and introduction of particulate matter into the container (40). <IMAGE>
Patent NZ-253421-A (NZ)
Title: Catalyst support comprising a carbon fibril aggregate; catalysts; use thereof
Inventor: MOY DAVID
IPC: C07C5/367
Filed: 1993-05-12
Abstract: A supported catalyst comprising a carbon fibril aggregate and a catalytically effective amount of a catalyst supported therein, a process for performing a catalytic reaction in fluid phase using the supported catalyst and a process for making the supported catalyst are disclosed. <IMAGE>
Patent NZ-270624-A (NZ)
Title: Fluorinated vitamin d3 derivative and medicaments
Inventor: DORAN THOMAS I
IPC: A61P3/02
Filed: 1995-03-03
Abstract: This invention is for 1α-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol, which can be further characterized by the formula:and which is useful as an agent for the treatment of sebaceous gland diseases such as acne and sebhorreic dermatitis. It can be prepared by removing the silyl protecting groups from a corresponding compound with silyl protected hydroxy groups.
Patent NZ-272143-A (NZ)
Title: 11,21-bisphenyl-19-norpregnane derivatives; medicaments and preparation thereof
Inventor: GEBHARD RONALD
IPC: A61P25/24
Filed: 1995-05-17
Abstract: The invention relates to a 11,21-bisphenyl-19-norpregnane derivative of formula I <CHEM> wherein R1 is selected from H, halogen, (1-6C)alkoxy, and NR5R6, R5 and R6 being independently hydrogen or (1-6C)alkyl or R5 and R6 together are (3-6C)alkylene; R2 is hydrogen; or R1 and R2 together are a (1-3C)alkylenedioxy group, optionally substituted by one or more halogen atoms; R3 is methyl or ethyl; R4 is selected from C(O)-NR5R6, SOn-(1-6C)alkyl optionally substituted by one or more halogen atoms, SOn-(3-6C)cycloalkyl, n being 1 or 2, SO2-NR5R6, 2-oxypyrrolidinyl, and NR5R6; R7 is H or (1-6C)alkyl; R8 is H or carboxy-1-oxo(1-6C)alkyl; and X is selected from (H,OH), O, and NOH; 11  or a pharmaceutically acceptable salt thereof. The compounds of the invention have anti-glucocorticoid activity and can be used in treating or preventing glucocorticoid-dependent diseases.
Patent NZ-299405-A (NZ)
Title: Serum based vaccine comprising antigen and adjuvant free of non-host albumin and its preparation
Inventor: HENNESSY KRISTINA J
IPC: A61K39/116
Filed: 1996-09-18
Abstract: Disclosed herein is a serum-based adjuvanted vaccine which is substantially free of non-host albumin and the use thereof in reducing or preventing post-vaccination systemic reactions.